Overview
Drugs in R&D publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval.
The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.
Manuscripts accepted for publication by the journal are subject to an article processing charge (APC). Details of the current APC and open access funding and support services are available here.
Drugs in R&D offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
- Editor
-
- Anton van Rensburg
- Impact factor
- 3.0 (2022)
- 5 year impact factor
- 3.1 (2022)
- Submission to first decision (median)
- 12 days
- Downloads
- 384,158 (2023)
Latest articles
Journal updates
-
Digital Features
Drugs in R&D is able to host a range of digital features, with a number of options available to authors.
Journal information
- Electronic ISSN
- 1179-6901
- Print ISSN
- 1174-5886
- Abstracted and indexed in
-
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- DOAJ
- Dimensions
- EBSCO
- EMBASE
- Gale
- Google Scholar
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- PubMedCentral
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information